MADISON, N.J., Feb. 5, 2014 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced today that its ChartMaxx® enterprise content management technology (ECM) solution was ranked the top healthcare Document Management and Imaging (DMI) software product, according to the 2013 Best in KLAS: Software & Services report, an independent ranking based on customer feedback from healthcare information technology (HIT) providers. ChartMaxx secured the highest overall score and product quality rating in the DMI category.
2013 marks the ninth time ChartMaxx has ranked in the Best in KLAS survey, making it the most frequently awarded product in the DMI category. DMI software is used to scan, create, archive, streamline workflows and validate electronically stored documents and images for hospitals and health organizations to complement their EHR, enterprise resource planning (ERP), and financial systems where additional enterprise data needs to be captured and accessed for better patient care.
"We listened to the providers, and these are the results," said Adam Gale, CEO and president of KLAS Research. "This report isn't about KLAS. It is a reflection of thousands of providers who wanted to be heard and counted. That is the reason top-performing vendors should be proud of their achievements."
The ChartMaxx product suite has helped more than 170 healthcare providers improve their enterprise health document management for more than 15 years, enabling healthcare organizations to enhance workflow performance through the efficient collection of enterprise content from clinical, financial, human resources and administrative information. Quest's award-winning implementation, integration, consulting and process re-engineering services in support of ChartMaxx help healthcare organizations define, streamline and automate departmental workflows, improving efficiencies as well as clinical care
"The ChartMaxx solution provides significant value to physicians, hospital administrators and CIOs requiring an intuitive, enterprise-wide solution for their healthcare document and data management needs," said Philip Present, vice president and general manager, Quest Diagnostics Care360 and ChartMaxx Products. "As healthcare becomes increasingly data driven, hospitals and physicians need interoperable solutions that capture and showcase the entire medical record to help them make informed clinical decisions and enhance the patient experience."
Added Mr. Present: "The Best in KLAS distinction is more than an affirmation of our commitment to providing solutions, support, and services that delight our customers. We believe it reflects Quest's ability to create innovative solutions to help healthcare professionals use diagnostic insights and other healthcare information to improve patient care."
ChartMaxx will be showcased at the Quest Diagnostics exhibit (3064) during the 2014 HIMSS Conference & Exhibition, February 23-27, in Orlando.
KLAS is a research firm on a global mission to improve healthcare delivery by enabling providers to be heard and counted. Working with thousands of healthcare professionals and clinicians, KLAS gathers data on software, services, medical equipment and infrastructure systems to deliver timely reports, trends and statistical overviews. The research directly represents the provider voice and acts as a catalyst for improving vendor performance. Follow KLAS on Twitter at www.twitter.com/KLASresearch.
About Quest Diagnostics
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at QuestDiagnostics.com and product information available at ChartMaxx.com
Quest Diagnostics Contacts
Wendy Bost (Media): 973-520-2800
Dan Haemmerle (Investors): 973-520-2900
SOURCE Quest Diagnostics